Newron Pharmaceuticals SpA (NWRN) — Capital Reinvestment Ratio
Newron Pharmaceuticals SpA (NWRN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF33.35 Million) in capital expenditures (CHF31.00K). See Newron Pharmaceuticals SpA balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Newron Pharmaceuticals SpA Capital Reinvestment Ratio (2012–2025)
This chart tracks Newron Pharmaceuticals SpA's Capital Reinvestment Ratio across 2 annual periods. Check NWRN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Newron Pharmaceuticals SpA (2012–2025)
Year-by-year Capital Reinvestment Ratio for Newron Pharmaceuticals SpA from 2012 to 2025. For live market cap and broader valuation context, see Newron Pharmaceuticals SpA stock valuation.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CHF32.56 Million | CHF47.30K | ▼ -23.1% |
| 2012 | 0.00x | CHF5.83 Million | CHF11.00K | — |